Brief: Aeon Biopharma, Inc. Announces Pricing Of Approximately $20.0 Million Underwritten Public Offering
06/01/2025 14:56
Jan 6 (Reuters) - Aeon Biopharma Inc AEON.A :
* AEON BIOPHARMA, INC. ANNOUNCES PRICING OF APPROXIMATELY
$20.0
MILLION UNDERWRITTEN PUBLIC OFFERING
* AEON BIOPHARMA INC - PUBLIC OFFERING PRICE PER COMMON UNIT
IS
$0.50
* AEON BIOPHARMA INC - TRANSACTION EXPECTED TO CLOSE ON
JANUARY 7,
2025
Source text: ID:nGNX1XBCp3
Further company coverage: AEON.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition